CLOSE

Specials

  • March
  • BioTech Startups
  • Genomics Europe
  • Bioanalytical Services Europe
  • Sustainable Technologies
  • BioTech Startup APAC
  • Life Science Packaging
  • Europe
  • APAC
  • Bioanalytical Services APAC
  • Life Science Compliance
  • Life Science Analytics
  • Bioanalytical Services
  • September
  • June
  • Contract Research Organization

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
APAC
EUROPE
  • Home
  • News
  • Contributors
  • Magazine
  • Conferences
  • Newsletter
  • About

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

Contract Research Organization: Top Benefits

Contract Research Organization: Top...

The Potential of Strategic Partnering with CROs

The Potential of Strategic Partnering...

Data Aided Risk Management in the Life Sciences Industry

Data Aided Risk Management in the...

Top Biotech Developments to Watch for

Top Biotech Developments to Watch for

Grasslands turning from carbon sinks to emitters

Grasslands turning from carbon sinks...

Being hopeful about the environment in 2021

Being hopeful about the environment...

Must-Know Biotechnology Trends in 2021

Must-Know Biotechnology Trends in 2021

The Role of Technology in the Biotech Sector

The Role of Technology in the Biotech...

Contract Research Organization: Top Benefits

Contract Research Organization: Top...

The Potential of Strategic Partnering with CROs

The Potential of Strategic Partnering...

Data Aided Risk Management in the Life Sciences Industry

Data Aided Risk Management in the...

Top Biotech Developments to Watch for

Top Biotech Developments to Watch for

Grasslands turning from carbon sinks to emitters

Grasslands turning from carbon sinks...

Being hopeful about the environment in 2021

Being hopeful about the environment...

Must-Know Biotechnology Trends in 2021

Must-Know Biotechnology Trends in 2021

The Role of Technology in the Biotech Sector

The Role of Technology in the Biotech...

Using AI to Prevent Adverse Effects of Immunotherapy

By Life Sciences Review | Friday, February 26, 2021
Tweet

Analysis of radiomic features on pre-treatment performed scans could offer a non-invasive way to identify patients.


FREMONT, CA: Until recently, researchers had placed these lung cancer patients into two broad categories, including people who would benefit from immunotherapy and those who likely would not. But the third category of patients called hyper-progressors who would be affected by immunotherapy, including a shortened lifespan after treatment, has begun to emerge. This is a major subset of patients who should potentially avoid immunotherapy completely. Eventually, researchers want this to be integrated into clinical settings to have all the data required to make the call for each patient.


Presently, only about 20 percent of all cancer patients will get value from immunotherapy. This treatment differs from chemotherapy because it uses drugs to support the immune system fight cancer, while chemotherapy leverages drugs to directly kill cancer cells. The CCIPD is a pioneer in detecting, diagnosing, and characterizing many cancers and other diseases by meshing medical imaging, machine learning, and AI. 


CCIPD scientists demonstrated that AI and machine learning could be leveraged to predict which lung cancer patients will benefit from immunotherapy.


This is an important finding because it illustrates that radiomic patterns from routine CT scans can discern three kinds of response in lung cancer patients undergoing immunotherapy treatment--responders, non-responders, and hyper-progressors. In this and previous research, researchers from Case Western Reserve and Cleveland Clinic essentially teach computers to seek and find patterns in CT scans taken when lung cancer is first diagnosed to reveal data that could have been useful if known before treatment. And because many cancer patients have benefitted from immunotherapy, researchers are looking for a better way to identify who would most likely respond to those treatments.


As with any previous cancer research at the CCIPD, researchers again found some significant clues to which patients would be harmed by immunotherapy outside the tumor.  The radiomic features outside the tumor were predictive than those inside the tumor, and alterations in the blood vessels surrounding the nodule were also more predictive.


Weekly Brief

loading
Towards a New World Order
> <
  • Life Science Compliance 2021

    Top Vendors

    Current Issue
  • Other 2021

    Top Vendors

    Current Issue

Read Also

Genome Sequencing Technology Becoming More Efficient

Genome Sequencing Technology Becoming More Efficient

Contract Research Organization: Top Benefits

Contract Research Organization: Top Benefits

Genomics: How Can Employing AI Enhance Healthcare?

Genomics: How Can Employing AI Enhance Healthcare?

The Potential of Strategic Partnering with CROs

The Potential of Strategic Partnering with CROs
Advantages of Using Glass Pharmaceutical Packaging

Advantages of Using Glass Pharmaceutical Packaging

How Cloud-Based LIMS Helps CROs

How Cloud-Based LIMS Helps CROs

Pharma and Biotech are Looking to Cloud and AI to Expediate Drug Discovery

Pharma and Biotech are Looking to Cloud and AI to Expediate Drug Discovery

What You Should Know About Biotechnology

What You Should Know About Biotechnology
Loading...

Copyright © 2021 Life Science Review . All rights reserved. |  Subscribe follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/using-ai-to-prevent-adverse-effects-of-immunotherapy-nwid-271.html